New member | MAD-UP

Latest Posts

Ose Immunotherapeutics: license agreement with Veloxis Pharmaceuticals

31 January 2022

OSE Immunotherapeutics Announced Acceptance of the US Investigational New Drug (IND) Application Obtained by Veloxis Pharmaceuticals, Inc., its Partner in... View Article

CUREETY, the French start-up specialized in data and remote-monitoring in oncology, raises €5 million

The financing round was led by French mutual insurance companies, with the support of Cureety’s existing investors, bank pool and... View Article

New member | GenSensor

26 January 2022

By 2024, forecasts indicate that 50% of the top 100 most prescribed drugs will be biologics, accounting for 32% of... View Article

« Previous 1 … 27 28 29 30 31 … 160 Next »